latest update:
[RxAtlas]

drug summary · 4 NDC codes

Sunlenca 300 mg/1

LENACAPAVIR SODIUM

HUMAN PRESCRIPTION DRUG record from the RxAtlas dataset, marketing status NDA. Facts and NDC codes below are exported values from the current release, not inferred or edited prose.

dataset id 67132NDC codes 4application NDA215974RxCUI —

Facts

Field definitions, types, and provenance rules are in the data dictionary.

generic nameLENACAPAVIR SODIUM
active ingredientsLENACAPAVIR SODIUM
dosage formTABLET, FILM COATED
routeORAL
strength300 mg/1
marketing statusNDA
DEA schedulenot reported
application numberNDA215974
ATC codenot reported
RxCUInot reported
manufacturerGilead Sciences, Inc.
product typeHUMAN PRESCRIPTION DRUG
pharmacologic classBreast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; HIV Capsid Inhibitors [MoA]; Human Immunodeficiency Virus 1 Capsid Inhibitor [EPC]; P-Glycoprotein Inhibitors [MoA]

NDC codes

4 National Drug Codes are mapped to this product in the current release. Package descriptions are not part of the published export, so the NDC code is the canonical package identifier here.

NDCPackage description
61958-3001—
61958300101—
61958300102—
61958300103—

Other LENACAPAVIR SODIUM products

One other product in the current release publishes the same generic name. Strength, dosage form, and labeler are what distinguish them.

Work with this record

  • Field definitions

    Types, scope, and provenance rules for every exported field.

  • REST API

    Query the same gate-backed records programmatically.

  • Evaluation sample

    Download a bounded slice before buying.

  • $29 API Pass

    Seven days of REST and MCP access to the full catalogue; credited toward the licence.